Latest News

Priority Review Granted to PD-L1/4-1BB Bispecific Antibody Opamtistomig, Accelerating Commercialization and Addressing Unmet Need in EP-NEC

NANJING, China, July 10, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that the biologics license application (BLA) for Opamtistomig (LBL-024, a PD-L1/4-1BB bispecific antibody) as monotherapy for the treatment of adva...

2026-07-10 16:53 4235

STARTRADER Breaks Ground on Basketball Court Revamp Benefiting around 20,000 Students in Davao City, Philippines

The project marks STARCARES' latest CSR investment in accessible sports infrastructure for schools and communities. DAVAO CITY, Philippines, July 10, 2026 /PRNewswire/ -- STARTRADER has officially launched the redevelopment of the basketball court at Communal Elementary School in Buhangin, Davao...

2026-07-10 16:51 4172

Monport Launches GPro Vision MOPA Fiber Laser Series With Smart Vision Positioning, Color Marking and Auto Focus

LOS ANGELES, July 9, 2026 /PRNewswire/ -- Intelligent automation is reshaping laser processing as businesses increasingly invest in advanced fiber laser solutions that...

2026-07-10 12:08 2761

MicroCloud Hologram Inc. Practical Approximate Quantum Multiplier Achieves Low-Depth High-Fidelity Computation

SHENZHEN, China, July 9, 2026 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, has made an important breakthrough centered on the NISQ (Noisy Intermediate-Scale Quantum) environment — the practical approximate quantum multiplier te...

2026-07-09 23:55 3770

Amcor expands packaging facility in China

Investment reinforces Amcor's commitment to a key growth market ZURICH, July 9, 2026 /PRNewswire/ -- Amcor (NYSE: AMCR, ASX: AMC), a global leader in developing and producing responsible packaging solutions, has commenced an expansion project at its flexible packaging solutions facility in Dongg...

2026-07-09 22:48 9990

Beyond Tea Names: iTeaworld Launches Chinese Oolong Tea Flavor Roadmap to Simplify Tea Discovery for Global Consumers

New flavor-based navigation system and tasting collections help tea newcomers find their perfect oolong match without requiring expert knowledge SHENZHEN, China, July 9, 2026 /PRNewswire/ -- For many consumers, the biggest challenge in exploring Chinese oolong tea isn't lack of interest—it's not ...

2026-07-09 21:00 4247

TOYO participates in Citi's "10-Hour Teach-In: The Space Economy & Future of AI" Investor Webcast

Senior Technical Leadership Presents on Solar Applications in Space TOKYO, July 9, 2026 /PRNewswire/ -- TOYO Co., Ltd (Nasdaq: TOYO) (OTC: TOYWF), ("TOYO" or the "Company"), a solar manufacturing company,today anno unced that senior members of its leadership team participated in Citi's "10-Hour T...

2026-07-09 20:30 8026

POMDOCTOR LIMITED Continues to Advance AI-Enabled Chronic Disease Management Strategy Amid Growing Demand for Predictive Healthcare

GUANGZHOU, China, July 9, 2026 /PRNewswire/ -- POMDOCTOR LIMITED (the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions and predictive healthcare capabilities, today highlighted its continued efforts in building an AI-powered chronic disea...

2026-07-09 20:00 4376

Monport MEGAS Demonstrates How Intelligent Precision Is Redefining Desktop CO2 Laser Engraving

NEW YORK, July 9, 2026 /PRNewswire/ -- As laser engraving continues to expand across manufacturing, customization, education, and small business production, demand is growing for co...

2026-07-09 18:08 2914

Professor Gang Shen's Orthodontic Team Publishes Third Consecutive Paper in the Journal of Aligner Orthodontics

SHANGHAI, July 8, 2026 /PRNewswire/ -- Professor Gang Shen, Chief GS R&D Scientist of Smartee Denti-Technology and Chief Orthodontist at Taikang Dental, together with his orthodontic team, has published a new researcharticle titled " Pathological Mandibular Retrusion: Causality and Orthodontic Int...

2026-07-09 17:55 3592

InxMed Announces Publication in The Lancet Respiratory Medicine Featuring Promising Anticancer Activity of Ifebemtinib in combination with Garsorasib in First-Line non-small cell lung cancer (NSCLC) Harboring KRAS G12C Mutation

NANJING, China, July 9, 2026 /PRNewswire/ -- InxMed Co., Ltd ("InxMed"), a clinical-stage biotechnology company dedicated to developing innovative therapies targeting cancer treatment resistance and metastasis, today announced that the clinical results of ifebemtinib (IN10018), a highly selective...

2026-07-09 17:28 3737

Overseas Gallery of China National Silk Museum - Splendid Silk Exhibition Opens in Kazakhstan, Weaving a Tapestry of Cultural Exchange

ASTANA, Kazakhstan, July 9, 2026 /PRNewswire/ -- A vibrant celebration of Chinese silk art unfolded in Kazakhstan's capital on July 2, as the "Splendid Silk: Contemporary Chinese Silk Art International Touring Exhibition" officially opened at the National Museum of Kazakhstan. Hosted within the ...

2026-07-09 16:32 2926

WuXi Biologics' MFG8 Drug Substance Facility Secures FDA PLI Approval, Advancing Commercial Supply of a Potential Blockbuster Autoimmune Therapy

SHIJIAZHUANG, China, July 9, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its MFG8 drug substance manufacturing facility located in Hebei has successfully passed the Pre-License Inspection (PL...

2026-07-09 15:31 3677

RoboSense Announces H1 2026 LiDAR Sales of 719,200 Units as Robotics Segment Grows by 510.4%

* RoboSense recorded 719,200 units in LiDAR sales in H1 2026, up 169.6% year over year, with robotics LiDAR sales surging 510.4% to 282,600 units. * In Q2 2026, RoboSense recorded 388,900 units in LiDAR sales, including 97,100 units from robotics segment and 291,800 units from ADAS segment. S...

2026-07-09 15:09 2092

Arrow Global Insurance strengthens specialty insurance platform through acquisition of Fusion Specialty Group

Acquisition marks another significant milestone for Arrow Global Insurance, reinforcing its leadership in specialty insurance markets where disciplined underwriting is critical LONDON, July 9, 2026 /PRNewswire/ -- Arrow Global Group ("Arrow"), a leading pan-European alternative investment manage...

2026-07-09 14:00 2402

Narwal Unveils Flow 2 White - A Quiet Luxury Colorway Made to Blend Into Modern Living Spaces

Where Function Meets Aesthetics, Narwal Flow 2 White Merges Flagship-Grade Cleaning with Detail-Driven Design NEW YORK, July 9, 2026 /PRNewswire/ -- Narwal , a global leader in smart home cleaning, todayunveiled the Narwal Flow 2 White – a new, distinct colorway of its 202...

2026-07-09 12:03 3201

The biggest ninja show in "NARUTO" history! An ultra-large-scale project is born in Kyoto!

Long-run performances confirmed to start in February 2027! A brand-new ninja show of unprecedented scale is born at Minamiza Theatre in Kyoto! Its name: Ninja Show "NARUTO" Rewriting the history of entertainment, a "NARUTO" like no one has ever seen before is about to begin! KYOTO, Japan, July ...

2026-07-09 10:57 2622

Groundbreaking Achievement: Study of Ensartinib as Postoperative Adjuvant Therapy Published in The New England Journal of Medicine

HANGZHOU, China, July 8, 2026 /PRNewswire/ -- On July 8, the study of Betta's ensartinib as postoperative adjuvant therapy for patients with stage IB–IIIB (T3N2M0) ALK-positive non-small cell lung cancer (NSCLC), known as the ELEVATE study,was published online in full in The New England Journal o...

2026-07-09 10:16 3248

Chinese Cities' International Digital Image Index 2026 Unveiled in Zhongshan

ZHONGSHAN, China, July 8, 2026 /PRNewswire/ -- On May 23, the School of Journalism and Communication at Renmin University of China officially released theChina Cities Digital Image Index (2026) at the Third China Urban Online Image Innovation Forum in Zhongshan, Guangdong Province. The report ass...

2026-07-09 09:59 2299

HanchorBio Tests Broader Ambitions for HCB101 Through InxMed Partnership

Taiwan-listed biotech looks to expand the value of its lead oncology asset through combination research with late-stage cancer drug resistance specialist InxMed. TAIPEI and SHANGHAI and SAN FRANCISCO, July 8, 2026 /PRNewswire/ -- HanchorBio, Inc. (TWSE: 7827) is taking another step to broaden th...

2026-07-09 09:13 2962
1 ... 13141516171819 ... 1709

Week's Top Stories